Moderna seeks FDA approval for COVID vaccine booster shot

Published: Sep. 1, 2021 at 6:28 PM EDT|Updated: Sep. 1, 2021 at 6:37 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

(Gray News) - Moderna has submitted data to the Food and Drug Administration for a COVID-19 vaccine booster, according to a statement from the company.

“We are pleased to initiate the submission process for our booster candidate ... with the FDA,” said CEO Stéphane Bancel. “We remain committed to staying ahead of the virus and following the evolving epidemiology of SARS-CoV-2,”

In mid-August, U.S. health officials announced plans to give COVID-19 booster shots to all Americans to shore up their protection amid a surge in the highly contagious delta variant.

The booster plan calls for an extra dose eight months after people get their second shot of the Pfizer or Moderna vaccine.

Pfizer is also seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine.

The drugmaker said last week it has started the application process for a third dose of its vaccine for everyone ages 16 and older.

Copyright 2021 Gray Media Group, Inc. All rights reserved. The Associated Press contributed to this story.